Abstract
IgM secreting myelomas or lymphomas, including Waldenström macroglobulinemia, are associated with a varied spectrum of renal pathology, including intracapillary hyaline deposits, cryoglobulin, membranoproliferative glomerulonephritis, amyloid, monoclonal immunoglobulin deposition disease, cast nephropathy, and lymphoma infiltration. We report our single institution experience, and describe five cases with distinctive glomerular pathology: intracapillary IgM pseudothrombi and thrombotic microangiopathic change, with glomerular intracellular crystals in two biopsies. Two patients were hypocomplementemic at presentation. This series adds to the recent literature on paraprotein associated thrombotic microangiopathy.
Similar content being viewed by others
References
Swerdlow SH, Cook JR, Sohani AR, Pileri SA, Harris NL, Jaffe ES, Stein H (2017) Lymphoplasmacytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. IARC Press, Lyon 2017, pp 232–236
Kapoor P, Paludo J, Vallumsetla N, Greipp PR (2015) Waldenström macroglobulinemia: What a hematologist needs to know. Blood Rev 29:301–319
Yun S, Johnson AC, Okolo ON, Arnold SJ, McBride A, Zhang L, Baz RC, Anwer F (2017) Waldenström macroglobulinemia: review of pathogenesis and management. Clin Lymphoma Myeloma Leuk 17:252–262
Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y et al (2012) MYD88 L265P somatic mutation in Waldenström’s macroglobulinemia. N Engl J Med 367:826–833
Poulain S, Roumier C, Decambron A, Renneville A, Herbaux C, Bertrand E et al (2013) MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood 121:4504–4511
Hunter ZR, Xu L, Yang G, Zhou Y, Liu X, Cao Y et al (2014) The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood 123:1637–1646
Treon SP, Cao Y, Xu L, Yang G, Liu X, Hunter ZR (2014) Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia. Blood 123:2791–2796
Vos JM, Gustine J, Rennke HG, Hunter Z, Manning RJ, Dubeau TE, Meid K, Minnema MC, Kersten MJ, Treon SP, Castillo JJ (2016) Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes. Br J Haematol 175:623–630
Morel-Maroger L, Basch A, Danon F, Verroust P, Richet G (1970) Pathology of the kidney in Waldenström’s macroglobulinemia. Study of sixteen cases. N Engl J Med 283:123–129
Audard V, Georges B, Vanhille P, Toly C, Deroure B, Fakhouri F, Cuvelier R, Belenfant X, Surin B, Aucouturier P, Mougenot B, Ronco P (2008) Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum. Clin J Am Soc Nephrol 3:1339–1349
Yahata M, Nakaya I, Takahashi S, Sakuma T, Sato H, Soma J (2012) Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenström’s macroglobulinemia: case report and review of the literature. Clin Nephrol 77:254–260
Chauvet S, Bridoux F, Ecotière L, Javaugue V, Sirac C, Arnulf B, Thierry A, Quellard N, Milin S, Bender S, Goujon JM, Jaccard A, Fermand JP, Touchard G (2015) Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients. Am J Kidney Dis 66:756–767
Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL et al (2018) Kidney involvement of patients with Waldenstrom Macroglobulinemia and other IgM-producing B cell lymphoproliferative disorders. Clin J Am Soc Nephrol 13:1037–1046
Haraguchi S, Tomiyoshi Y, Aoki S, Sakemi T (2002) Nephrotic syndrome due to immunologically mediated hypocomplementemic glomerulonephritis in a patient of Waldenström’s macroglobulinemia. Nephron 92:452–455
Da’as N, Kleinman Y, Polliack A, Amir G, Ne’eman Z, Kopolovic J et al. (2001) Immunotactoid glomerulopathy with massive bone marrow deposits in a patient with IgM kappa monoclonal gammopathy and hypocomplementemia. Am J Kidney Dis 38:395–399
Pérez NS, Garcia-Herrera A, Rosiñol L, Palos L, Santiago E, Espinosa G, Solé M, Campistol JM, Quintana LF (2012) Lymphoplasmacytic lymphoma causing light chain cast nephropathy. Nephrol Dial Transplant 27:450–453
Gnemmi V, Leleu X, Provot F, Moulonguet F, Buob D (2012) Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia. Am J Kidney Dis 60:487–491
Salviani C, Guido G, Serriello I, Giannakakis K, Rocca AR (2014) Renal involvement in Waldenström’s macroglobulinemia: case report and review of literature. Ren Fail 36:114–118
Wu CK, Leu JG, Yang AH, Tarng DC, Tung HY, Chiang SS (2016) Simultaneous occurrence of fibrillary glomerulonephritis and renal lesions in nonmalignant monoclonal IgM gammopathy. BMC Nephrol 17:17
Hoelbeek J, Duivenvoorden R, de Boer OJ, Claessen N, Van den Bergh Weerman MA, Roelofs JJ, Kers J, Ten Berge IJ, Florquin S (2016) Unique renal manifestation of type I cryoglobulinemia, with massive crystalloid deposits in glomerular histiocytes, podocytes, and endothelial cells. Am J Clin Pathol 145:282–285
Ravindran A, Go RS, Fervenza FC, Sethi S (2017) Thrombotic microangiopathy associated with monoclonal gammopathy. Kidney Int 91:691–698
Lin M, Haas M (2017) Paraprotein-associated thrombotic microangiopathy: expanding the spectrum of renal disease related to plasma cell dyscrasias. Kidney Int 91:532–534
Schurder J, Rafat C, Vigneron C (2017) Complement-dependent, monoclonal gammopathy-associated thrombotic microangiopathy. Kidney Int 92:516
Mahmood U, Isbel N, Mollee P, Mallett A, Govindarajulu S, Francis R (2017) Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome. Nephrology (Carlton) 22(Suppl 1):15–17
Cheungpasitporn W, Leung N, Sethi S, Gertz MA, Fervenza FC (2015) Refractory atypical hemolytic uremic syndrome with monoclonal gammopathy responsive to bortezomib-based therapy. Clin Nephrol 83:363–369
Motwani SS, Herlitz L, Monga D, Jhaveri KD, Lam, American Society of Nephrology Onco-Nephrology Forum (2016) Paraprotein-related kidney disease: glomerular diseases associated with paraproteinemias. Clin J Am Soc Nephrol 11:2260–2272
Yao H, Monge M, Renou M, Lecaque C, Jauréguy M, Presne C, Makdassi R, Choukroun G (2014) Thrombotic thrombocytopenic purpura due to anti-ADAMTS13 antibodies in multiple myeloma. Clin Nephrol 81:210–215
Marcantoni C, Emmanuele C, Scolari F (2016) Renal involvement in primary antiphospholipid syndrome. J Nephrol 29:507–515
Nochy D, Daugas E, Droz D, Beaufils H, Grünfeld JP, Piette JC et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507–518
Fakhouri F, Noël LH, Zuber J, Beaufils H, Martinez F, Lebon P et al (2003) The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis 41:1205–1211
Acknowledgements
The authors thank Norm Cyr for expert assistance with digital and graphical figures. This data was presented in abstract form at the United States & Canadian Academy of Pathology meeting in Vancouver, BC, Canada, March 2018.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical approval
This study was approved by the Institutional Review Board at Stanford University Medical Center (#37478), with a waiver of patient consent.
Rights and permissions
About this article
Cite this article
Tan, S.Y.S., Sibley, R.K., Belani, S. et al. Thrombotic microangiopathy with intraglomerular IgM pseudothrombi in Waldenström macroglobulinemia and IgM monoclonal gammopathy. J Nephrol 31, 907–918 (2018). https://doi.org/10.1007/s40620-018-0544-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-018-0544-9